Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Emanuel

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Blood|January 11, 2000
Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitorsP D Emanuel, R C Snyder, T Wiley, et al.
American Journal of Hematology|March 1, 1996
Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and reviewE A Lowenthal, A Wells, P D Emanuel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Specific inhibition of interleukin 3 bioactivity by a monoclonal antibody reactive with hematopoietic progenitor cellsP D Emanuel, S C Peiper, Z Chen, et al.
Blood|March 1, 1991
Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitorsP D Emanuel, L J Bates, R P Castleberry, et al.
Leukemia|February 19, 2013
Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemiaY L Liu, S Y Lensing, Y Yan, et al.
Experimental Hematology|November 1, 1991
The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemiaP D Emanuel, L J Bates, S W Zhu, et al.
Blood|June 25, 1998
Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1L E Side, P D Emanuel, B Taylor, et al.
Blood|April 1, 1992
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftmentJ E Wagner, H E Broxmeyer, R L Byrd, et al.
The New England Journal of Medicine|December 22, 1994
A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemiaR P Castleberry, P D Emanuel, K S Zuckerman, et al.
Blood|June 1, 1992
Familial and congenital polycythemia in three unrelated familiesP D Emanuel, C J Eaves, V C Broudy, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Blood|January 11, 2000
Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitorsP D Emanuel, R C Snyder, T Wiley, et al.
American Journal of Hematology|March 1, 1996
Sickle cell acute chest syndrome associated with parvovirus B19 infection: case series and reviewE A Lowenthal, A Wells, P D Emanuel, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1990
Specific inhibition of interleukin 3 bioactivity by a monoclonal antibody reactive with hematopoietic progenitor cellsP D Emanuel, S C Peiper, Z Chen, et al.
Blood|March 1, 1991
Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitorsP D Emanuel, L J Bates, R P Castleberry, et al.
Leukemia|February 19, 2013
Deficiency of CREB and over expression of miR-183 in juvenile myelomonocytic leukemiaY L Liu, S Y Lensing, Y Yan, et al.
Experimental Hematology|November 1, 1991
The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemiaP D Emanuel, L J Bates, S W Zhu, et al.
Blood|June 25, 1998
Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1L E Side, P D Emanuel, B Taylor, et al.
Blood|April 1, 1992
Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftmentJ E Wagner, H E Broxmeyer, R L Byrd, et al.
The New England Journal of Medicine|December 22, 1994
A pilot study of isotretinoin in the treatment of juvenile chronic myelogenous leukemiaR P Castleberry, P D Emanuel, K S Zuckerman, et al.
Blood|June 1, 1992
Familial and congenital polycythemia in three unrelated familiesP D Emanuel, C J Eaves, V C Broudy, et al.
Pageof 3